Vanda Pharmaceuticals Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio96.7766.6426.3730.79
Forward P/E21.7321.9422.59
P/S Ratio1.411.261.643.252.90
P/B Ratio0.520.450.791.731.58
Price/Tangible Book0.660.570.821.801.67
Price/FCF13.3613.7314.38
Price/OCF18.9713.0713.6113.88
Enterprise Value Ratios
EV/Revenue1.791.55
EV/EBITDA10.6912.74
EV/EBIT11.4014.08
EV/FCF7.557.68
Profitability & Returns
Return on Equity (ROE)-0.03%0.00%0.01%0.07%0.05%
Return on Assets (ROA)-0.04%-0.01%0.01%0.05%0.03%
Return on Invested Capital (ROIC)-0.24%-0.05%0.05%0.36%0.19%
Return on Capital Employed (ROCE)-0.07%-0.03%0.01%0.08%0.06%
Leverage & Solvency Ratios
Debt/Equity0.020.020.020.020.03
Debt/EBITDA0.950.260.41
Debt/FCF0.360.190.27
Liquidity Ratios
Current Ratio4.394.945.686.436.21
Quick Ratio4.224.825.476.256.03
Efficiency Ratios
Asset Turnover0.300.300.410.480.49
Inventory Turnover7.3411.6021.8922.2419.31
Yield & Distribution Ratios
Earnings Yield-0.07%0.01%0.01%0.04%0.03%
FCF Yield-0.07%-0.36%0.07%0.07%0.07%
Buyback Yield-0.01%-0.01%0.00%-0.03%-0.01%